Human Induced Pluripotent Stem Cells in Hepatology

Abstract

The discovery of the wide plasticity of most cell types means that it is now possible to produce virtually any cell type in vitro. This concept, developed because of the possibility of reprogramming somatic cells toward induced pluripotent stem cells, provides the opportunity to produce specialized cells that harbor multiple phenotypical traits, thus integrating genetic interindividual variability. The field of hepatology has exploited this concept, and hepatocyte-like cells can now be differentiated from induced pluripotent stem cells. This review discusses the choice of somatic cells to be reprogrammed by emergent new and nonintegrative strategies, as well as the application of differentiated human induced pluripotent stem cells in hepatology, including liver development, disease modeling, host-pathogen interactions, and drug metabolism and toxicity. The actual consensus is that hepatocyte-like cells generated in vitro present an immature phenotype. Currently, developed strategies used to resolve this problem, such as overexpression of transcription factors, mimicking liver neonatal and postnatal modifications, and re-creating the three-dimensional hepatocyte environment in vitro and in vivo, are also discussed.

Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis

“…Therefore, mechanistic steps should be viewed critically in light of the fact that recapitulation of human IDILI has largely not been experimentally feasible. However, these mechanistic studies in animal models and in vitro systems are important in developing therapeutic solutions and can also lead to the discovery of sorely needed biomarkers for IDILI and cell death subroutines [176]. …”

MicroRNAs in liver tissue engineering — New promises for failing organs

“…Such constructs would ideally be based on autologous cells -i.e., generated from the recipient/patient, which would not only circumvent the need for donor organs for cell isolation but eventually also the need for immunosuppression after implantation [27][28][29]. Bioengineered livers could ideally be generated "on demand" whenever a patient is in need of hepatic support.…”

From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on Dyslipidemia

“…The differentiation into Hepatocyte-Like Cells Many reports have demonstrated the in vitro generation of hepatic cells from hiPSCs [24]. Such procedures were made possible owing to the increased knowledge in development biology along with the study of different animal models including zebrafish, xenopus, chick, and mouse [25 • , 26, 27].…”